or Try an Advanced Search...

    Dyslipidemia Stocks List

    Symbol Grade Name % Change
    VKTX B Viking Therapeutics, Inc. 0.60
    ARGX C argenx SE -3.15
    MDGL D Madrigal Pharmaceuticals, Inc. 1.84
    ABT F Abbott Laboratories 1.41
    IONS F Ionis Pharmaceuticals, Inc. 0.91
    View As Page of Charts
    Related Industries: Biotechnology Medical Devices
    Related Stock Lists: Lipid Cancer Diabetes Thyroid Alcohol Biopharmaceutical Cholesterol Hypercholesterolemia Inflammation Medication Medicine Metabolic Disease Obesity Steatohepatitis Acromegaly Acute Myeloid Leukemia Alport Syndrome Amyloid Amyloidosis Anemia

    Related ETFs - A few ETFs which own one or more of the above listed Dyslipidemia stocks.

    Symbol Grade Name Weight
    IHI D iShares U.S. Medical Devices ETF 16.17
    EWK A iShares MSCI Belgium Capped Investable Market Index Fund 6.71
    ULTY C Tidal Trust II YieldMax Ultra Option Income Strategy ETF 5.68
    PJP A PowerShares Dynamic Pharmaceuticals 5.18
    SURI D Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 5.1
    View all Dyslipidemia ETFs...
    Compare ETFs
    Compare IHI to SURI Compare IHI to ULTY Compare ULTY to SURI

        Dyslipidemia Stocks Recent News

        Date Stock Title
        May 30 ARGX After Biohaven Kerfuffle, Immunovant Dives On A Surprise Delay
        May 30 ABT Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
        May 29 ABT Implied Volatility Surging for Abbot Laboratories (ABT) Stock Options
        May 29 ARGX Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study
        May 29 ARGX Biohaven Crashes After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump
        May 29 MDGL Madrigal Pharmaceuticals to Present Multiple Rezdiffra™ (resmetirom) and Health Economics Outcomes Research Abstracts in NASH/MASH at the EASL Congress
        May 28 IONS Ionis: Tough Run For Share Price Belies Multiple Reasons For Optimism
        May 28 VKTX Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It?
        May 28 IONS Ionis to hold donidalorsen Phase 3 data webcast
        May 27 VKTX This Biotech Stock is a “Strong Buy” According to Raymond James
        May 26 VKTX If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today
        May 24 ABT Abbott (ABT) Stock Sinks As Market Gains: Here's Why
        May 24 IONS The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics
        May 24 VKTX 2 Stocks That Could 10x by 2035
        May 24 MDGL Insider Sale at Madrigal Pharmaceuticals Inc (MDGL): Senior VP, Chief Pharmaceutical ...
        Related Industries: Biotechnology Medical Devices
        Related Stock Lists: Lipid Cancer Diabetes Thyroid Alcohol Biopharmaceutical Cholesterol Hypercholesterolemia Inflammation Medication Medicine Metabolic Disease Obesity Steatohepatitis Acromegaly Acute Myeloid Leukemia Alport Syndrome Amyloid Amyloidosis Anemia
        Dyslipidemia

        Dyslipidemia is an abnormal amount of lipids (e.g. triglycerides, cholesterol and/or fat phospholipids) in the blood. In developed countries, most dyslipidemias are hyperlipidemias; that is, an elevation of lipids in the blood. This is often due to diet and lifestyle. Prolonged elevation of insulin levels can also lead to dyslipidemia. Likewise, increased levels of O-GlcNAc transferase (OGT) may cause dyslipidemia.

        More about Dyslipidemia
        Browse All Tags